Search Results 1811-1820 of 17195 for Birth Control Evolution

  1. A Study to Identify Clinical Characteristics and Biomarkers of Disease Outcome, Progression, and Treatment Response in Participants with Treatment-resistant Focal Epilepsy - Mayo Clinic

    Failure of adequate trials of 4 AEDs, with at least 2 due to failure of seizure control, including current AEDs. Have a seizure frequency of ≥ 2 focal ...

  2. A Study of Ramucirumab Plus Docetaxel in Patients With Urothelial Cancer - Mayo Clinic

    ... controlled cardiac arrhythmia, psychiatric illness, or any other serious uncontrolled medical disorders. Have experienced any arterial or venothrombotic or ...

  3. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

    Uncontrolled hypertension despite optimal medical management (per investigator's assessment). Participating Mayo Clinic locations. Study statuses change ...

  4. Pterygopalatine Fossa Treatment for Acute Headache in Aneurysmal - Mayo Clinic

    The purpose of this study is to assess the efficacy and safety of PPF-block to mitigate opiod use requirements and improve headache pain control in patients ...

  5. MyokinE100 System: Closed Loop Electrical Muscle Stimulation To Mitigate ICU Acquired Weakness In Medical ICU Patients - Mayo Clinic

    * Is electrical muscle stimulation a practical way to help reduce muscle weakness in critically ill patients? Researchers will compare the control group ( ...

  6. Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer - Mayo Clinic

    The effectiveness and safety of TheraSphere will be evaluated in patients with colorectal cancer with metastases in the liver, who are scheduled to receive ...

  7. Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer - Mayo Clinic

    Known contraindications to sorafenib including allergic reaction, pill-swallowing difficulty, uncontrolled hypertension or history of cardiac disease ...

  8. Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy - Mayo Clinic

    Asthma control reached at an OCS dose of ≤5mg during run-in/OCS optimization phase; Qualifies for 3 consecutive dose reductions at Visits 2-4 and continues ...

  9. Study of Adjuvant Regorafenib vs Placebo in Patients with Node Positive Esophageal Cancer who Completed Pre-operative Therapy - Mayo Clinic

    ... management per physician discretion; Active or clinically significant cardiac disease including: Congestive heart failure - New York Heart Association (NYHA) ...

  10. Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas - Mayo Clinic

    management with medications because of inadequate pain control, or because of side effects of the pain medication. 4. If patients have an additional site of ...